Showing results (381-390 of 1,028) with videos related to

Sort By:
Pageof 103
The Lancet. Respiratory Medicine|December 11, 2020
Safety and immunogenicity of the adjunct therapeutic vaccine ID93 + GLA-SE in adults who have completed treatment for tuberculosis: a randomised, double-blind, placebo-controlled, phase 2a trialTracey A Day, Adam Penn-Nicholson, Angelique Kany Kany Luabeya, et al.
The Lancet. Respiratory Medicine|November 15, 2020
Safety and efficacy of inhaled nebulised interferon beta-1a (SNG001) for treatment of SARS-CoV-2 infection: a randomised, double-blind, placebo-controlled, phase 2 trialPhillip D Monk, Richard J Marsden, Victoria J Tear, et al.
The Lancet. Respiratory Medicine|October 11, 2020
Clinical impact of molecular point-of-care testing for suspected COVID-19 in hospital (COV-19POC): a prospective, interventional, non-randomised, controlled studyNathan J Brendish, Stephen Poole, Vasanth V Naidu, et al.
The Lancet. Respiratory Medicine|October 15, 2020
Age-sex specific pulmonary embolism-related mortality in the USA and Canada, 2000-18: an analysis of the WHO Mortality Database and of the CDC Multiple Cause of Death databaseStefano Barco, Luca Valerio, Walter Ageno, et al.
The Lancet. Respiratory Medicine|July 26, 2021
Advancing precision medicine for acute respiratory distress syndromeJeremy R Beitler, B Taylor Thompson, Rebecca M Baron, et al.
The Lancet. Respiratory Medicine|February 19, 2020
Effect of fixed-dose subcutaneous reslizumab on asthma exacerbations in patients with severe uncontrolled asthma and corticosteroid sparing in patients with oral corticosteroid-dependent asthma: results from two phase 3, randomised, double-blind, placebo-controlled trialsJonathan A Bernstein, J Christian Virchow, Kevin Murphy, et al.
The Lancet. Respiratory Medicine|February 23, 2020
Effect of early parenteral nutrition during paediatric critical illness on DNA methylation as a potential mediator of impaired neurocognitive development: a pre-planned secondary analysis of the PEPaNIC international randomised controlled trialFabian Güiza, Ilse Vanhorebeek, Sören Verstraete, et al.
The Lancet. Respiratory Medicine|May 14, 2022
Health outcomes in people 2 years after surviving hospitalisation with COVID-19: a longitudinal cohort studyLixue Huang, Xia Li, Xiaoying Gu, et al.
The Lancet. Respiratory Medicine|July 19, 2021
Icotinib versus chemotherapy as adjuvant treatment for stage II-IIIA EGFR-mutant non-small-cell lung cancer (EVIDENCE): a randomised, open-label, phase 3 trialJianxing He, Chunxia Su, Wenhua Liang, et al.
The Lancet. Respiratory Medicine|January 18, 2021
Lung microbiota predict chronic rejection in healthy lung transplant recipients: a prospective cohort studyMichael P Combs, David S Wheeler, Jenna E Luth, et al.
Pageof 103